Andres A Gutierrez Md Phd Email Address

Executive Vice President and Chief Medical Officer

Advaxis is a clinical-stage biotechnology company developing immunotherapies for cancer and infectious diseases.

Experienced clinical oncologist and scientist with a proven record of drug development of small molecules and biologics, regulatory filings and fundraising activities. This includes more than 15 years of global clinical development experience including optimization of strategic development, and oversight of scientific, clinical, regulatory and financial objectives for clinical programs in oncology. Relevant participation in the development of small molecules (e.g., carfilzomib, talazoparib, JAK2i), antibodies (e.g., nivolumab, ipilimumab, anti-LAG3 & CXCR4) and biologic agents (e.g., oncolytic viruses, adenovirus & Lm vectors) in phase 1-4 trials in the US and abroad.